Analysts Set Integer Holdings Co. (NYSE:ITGR) Target Price at $146.56

Shares of Integer Holdings Co. (NYSE:ITGR - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $146.56.

ITGR has been the topic of a number of recent analyst reports. Piper Sandler reissued an "overweight" rating and issued a $140.00 price objective (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Citigroup increased their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a report on Wednesday, December 11th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Truist Financial upped their target price on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Finally, Benchmark boosted their price objective on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, October 21st.

Integer Price Performance

Shares of NYSE:ITGR traded down $0.05 during trading on Friday, reaching $140.95. The stock had a trading volume of 50,273 shares, compared to its average volume of 207,906. The stock has a market capitalization of $4.73 billion, a PE ratio of 43.52, a P/E/G ratio of 1.79 and a beta of 1.13. Integer has a 52 week low of $97.49 and a 52 week high of $146.36. The business's 50-day moving average price is $137.90 and its 200 day moving average price is $132.00. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Institutional Trading of Integer

A number of institutional investors have recently bought and sold shares of the business. Squarepoint Ops LLC lifted its stake in shares of Integer by 25.7% in the 4th quarter. Squarepoint Ops LLC now owns 3,162 shares of the medical equipment provider's stock valued at $419,000 after purchasing an additional 646 shares during the period. Teza Capital Management LLC increased its holdings in Integer by 11.6% in the fourth quarter. Teza Capital Management LLC now owns 2,727 shares of the medical equipment provider's stock valued at $361,000 after purchasing an additional 284 shares during the last quarter. ProShare Advisors LLC lifted its stake in Integer by 44.4% in the fourth quarter. ProShare Advisors LLC now owns 10,051 shares of the medical equipment provider's stock valued at $1,332,000 after buying an additional 3,091 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Integer by 3.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,678 shares of the medical equipment provider's stock worth $2,740,000 after buying an additional 685 shares during the last quarter. Finally, Fred Alger Management LLC acquired a new position in shares of Integer during the 4th quarter worth about $2,545,000. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.